Answers are grounded in this paper and cite their sources.
In this work, mesoporous silica nanoparticles (MSNs) were synthesized and loaded by curcumin (MSNs-CU) and capped by chitosan glycerol phosphate hydrogel (CS/βGH/MSNs-CU). Both of CS/βGH/MSNs-CU and MSNs-CU were characterized and analyzed, then, the cell viability of epithelial breast tumor cells (MCF-7) and healthy primary human mammary fibroblasts (HPHMF) treated by these nanocarriers, free-CU and the CU dispersed in CS/βGH hydrogel were studied. The CU release of CS/βGH, CS/βGH/MSNs-CU, and MSNs-CU was studied in the simulated body fluid (SBF) and results showed CU release from CS/GP/CU, MSNs-CU and CS/βGP/MSNs-CU was 4, 13.19, 8.87% after 24h, respectively. Optimum loading and encapsulation efficiency percentages of CU into MSNs were obtained 25% and 99% in 24 h, respectively. The MTT assay showed MSNs, MSNs-CU, CU, CS/βGP, CS/βGP/CU, CS/βGP/MSNs-CU had no influence on HPHMF cells. Also, free-CU, MSNs-CU showed cytotoxicity in the concentrations upper than 100 µg/mL and 10 µg/mL against MCF-7 cells after 24h, respectively. No reduction of MCF-7 cell viability was observed in treated cells by CS/βGP/CU and CS/βGP/MSNs-CU after 24h or 48 h which can be attributed to trapping of CU in the cohesive network of hydrogel formed, thus, release of CU was so slowly in the treated cells or SBF.
No takes yet. Share an insight, caveat, or question.
Rashidi et al. (2022) studied this question.